Computational Development of Selective nNOS Inhibitors: Binding Modes and Pharmacokinetic Considerations

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|21|2558-2579

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.21, 2015-01, pp. : 2558-2579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Computational Studies of Competitive Inhibitors of Nitric Oxide Synthase (NOS) Enzymes: Towards the Development of Powerful and Isoform-Selective Inhibitors

By  

Current Medicinal Chemistry, Vol. 13, Iss. 16, 2006-07 ,pp. : 1929-1946

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Selective Nitric Oxide Synthase (NOS) Inhibitors

By  

Current Pharmaceutical Design, Vol. 8, Iss. 3, 2002-02 ,pp. : 177-200

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations

By Wang Yow-Ming   Chow Andrew  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 46-61

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacokinetic Considerations in Development of a Bioartificial Liver

By Iwata H.   Ueda Y.  

Clinical Pharmacokinetics, Vol. 43, Iss. 4, 2004-01 ,pp. : 211-225

Adis International

Access to resources Recommend Favorite

The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors

By Filippatos Theodosios D   Athyros Vasilios G   Elisaf Moses S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 787-812

Informa Healthcare

Access to resources Recommend Favorite